These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 10976610)

  • 1. Drug injection rates and needle-exchange use in New York City, 1991-1996.
    Marmor M; Shore RE; Titus S; Chen X; Des Jarlais DC
    J Urban Health; 2000 Sep; 77(3):359-68. PubMed ID: 10976610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China.
    Luo W; Wu Z; Poundstone K; McGoogan JM; Dong W; Pang L; Rou K; Wang C; Cao X
    Addiction; 2015 Jan; 110 Suppl 1():61-7. PubMed ID: 25533865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.
    Hagan H; Thiede H
    J Urban Health; 2000 Sep; 77(3):369-82. PubMed ID: 10976611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringe and needle exchange as HIV/AIDS prevention for injection drug users.
    Watters JK; Estilo MJ; Clark GL; Lorvick J
    JAMA; 1994 Jan; 271(2):115-20. PubMed ID: 8264065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of syringe exchange use on high-risk injection drug users: a cohort study.
    Bluthenthal RN; Kral AH; Gee L; Erringer EA; Edlin BR
    AIDS; 2000 Mar; 14(5):605-11. PubMed ID: 10780722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV incidence among injecting drug users in New York City syringe-exchange programmes.
    Des Jarlais DC; Marmor M; Paone D; Titus S; Shi Q; Perlis T; Jose B; Friedman SR
    Lancet; 1996 Oct; 348(9033):987-91. PubMed ID: 8855855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
    Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
    JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued risky injection subsequent to syringe exchange use among injection drug users in New York City.
    Paone D; Des Jarlais DC; Caloir S; Jose B; Shi Q; Friedman SR
    AIDS Educ Prev; 1997 Dec; 9(6):505-10. PubMed ID: 9451478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic proximity, policy and utilization of syringe exchange programmes.
    Rockwell R; Des Jarlais DC; Friedman SR; Perlis TE; Paone D
    AIDS Care; 1999 Aug; 11(4):437-42. PubMed ID: 10533536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus.
    Shah NG; Celentano DD; Vlahov D; Stambolis V; Johnson L; Nelson KE; Strathdee SA
    AIDS; 2000 Sep; 14(13):2035-43. PubMed ID: 10997409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex, drugs, and syringe exchange in New York City: women's experiences.
    Paone D; Caloir S; Shi Q; Des Jarlais DC
    J Am Med Womens Assoc (1972); 1995; 50(3-4):109-14. PubMed ID: 7657943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs.
    Des Jarlais DC; Paone D; Friedman SR; Peyser N; Newman RG
    Am J Public Health; 1995 Nov; 85(11):1577-84. PubMed ID: 7485676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.
    Bluthenthal RN; Anderson R; Flynn NM; Kral AH
    Drug Alcohol Depend; 2007 Jul; 89(2-3):214-22. PubMed ID: 17280802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coverage of harm reduction services and HIV infection: a multilevel analysis of five Chinese cities.
    Wu Q; Kamphuis C; Duo L; Luo J; Chen Y; Richardus JH
    Harm Reduct J; 2017 Feb; 14(1):10. PubMed ID: 28193236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
    Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Hagan H; Beatrice S; Smith L; Wethers J; Milliken J; Mildvan D; Yancovitz S; Friedman SR
    AIDS; 2005 Oct; 19 Suppl 3():S20-5. PubMed ID: 16251819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997.
    Des Jarlais C; Perlis T; Friedman SR; Chapman T; Kwok J; Rockwell R; Paone D; Milliken J; Monterroso E
    Am J Public Health; 2000 Jul; 90(7):1112-6. PubMed ID: 10897190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.